Suramin inhibits wound healing following filtering procedures for glaucoma

British Journal of Ophthalmology

Volumn 82, Issue 7, 1998, Pages 816-820

  Mietz, Holger ^a,c   Chévez Barrios, Patricia ^a   Feldman, Robert M ^b   Lieberman, Michael W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; GROWTH FACTOR RECEPTOR; MITOMYCIN C; SURAMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CILIARY BODY; CILIARY BODY EPITHELIUM; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; FIBROSIS; FILTERING OPERATION; GLAUCOMA; HISTOPATHOLOGY; INTRAOCULAR PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TRABECULECTOMY; WOUND HEALING;

EID: 0031844552     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.7.816     Document Type: Article

References (32)

1. Quigley HA, Addicks EM, Geen WR. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol 1982;100:135-46.
2. Hayreh SS. The 1994 von Sallman lecture. The optic nerve head circulation in health and disease. Exp Eye Res 1995;61:259-72.
3. Cairns JE. Trabeculectomy: preliminary report of a new method. Am J Ophthalmol 1968;66:673-9.
4. Nouri-Mahdavi K, Brigatti L, Weitzman M, et al. Outcomes of trabeculectomy for primary open-angle glaucoma. Ophthalmology 1995;102:1760-9.
5. Hitchings RA, Grierson I. Clinicopathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc UK 1983;103:84-8.
6. Teng CC, Chi HH, Katzin HM. Histology and mechanism of filtering operations. Am J Ophthalmol 1959;47:16-34.
7. Broadway D, Hitchings R, Gierson I. Topical antiglaucomatous therapy:adverse effects on the conjunctiva and implications for filtering surgery. J Glaucoma 1995;4:136-48.
8. Jampel HD, McGuigan LJB, Dunkelberger GR, et al. Cellular proliferation after experimental glaucoma filtration surgery. Arch Ophthalmol 1988;106:89-94.
9. Khaw PT, Occleston NL, Schultz G, et al. Activation and suppression of fibroblast function. Eye 1994;8:188-195.
10. Araujo SV, Spaeth GL, Roth SM, et al. A ten-year follow-up on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy. Ophthalmology 1995; 102:1753-9.
11. The Fluorouracil Filtering Study Group. Five-year follow-up of the fiuorouracil filtering study group. Am J Ophthalmol 1996;121:349-66.
12. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology 1991;98:317-21.
13. Chamberlain J, Shah M, Ferguson MW. The effect of suramin on healing adult rodent dermal wounds. J Anal 1995;186:87-96.
14. Campochiaro PA, Hackett SF, Vinores SA, et al. Platelet-derived growth factor is an autocrine growth stimulator in retianl pigmented epithelial cells. J Cell Sci 1994;107:2459-69.
15. Zumkeller W, Schofield PN. Growth factors, cytokines and soluble forms of receptor molecules in cancer patients. Anticancer Res 1995;15:344-8.
16. Stein CA. Suramin: a novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res 1993;53: 2239-48.
17. Thomas DW, O'Neill ID, Harding KG, et al. Cutaneous wound healing: a current perspective. J Oral Maxillofac Surg 1995;53:442-7.
18. Lin RY, Sullivan KM, Argenta PA, et al. Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair. Ann Surg 1995;222:146-54.
19. Doxey DL, Ng MC, Dill RE, et al. Platelet-derived growth factor levels in wounds of diabetic rats. Life Sci 1995;57: 1111-23.
20. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-92.
21. Pierce GF, Tarpley JE, Tseng J, et al. Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest 1995;96:1336-50.
22. Sullivan KM, Lorenz HP, Meuli M, et al. A model of scarless human fetal wound repair is deficient in transforming growth factor beta. J Pediatr Surg 1995;30: 198-203.
23. Pejnovic N, Lilic D, Zunic G, et al. Aberrant levels of cytokines within the healing wound after burn injury. Arch Surg 1995;130:999-1006.
24. Shah M, Foreman DM, Ferguson MW. Control of scarring in adult wounds by neutralising antibody to transforming growth factor β. Lancet 1992;339:213-14.
25. Murali S, Hardten DR, DeMartelaere S, et al. Effect of topically administered platelet-derived growth factor on corneal wound strength. Curr Eye Res 1994;13:857-62.
26. Deuel TF, Kawahara RS. Growth factors and wound healing: platelet-derived growth factor as a model cytokine. Annu Rev Med 1991;42:567-84.
27. Levine JH, Moses HL, Gold LI, et al. Spatial and temporal paterns of immunoreactive transforming growth factor β1, β2, and β3 during excisional wound repair. Am J Pathol 1993;143:368-80.
28. Miller MH, Grierson I, Unger WI, et al. Wound healing in an animal model of glaucoma fistulizing surgery in the rabbit. Ophthalmic Surg 1989;20:350-7.
29. Seetner A, Morin JD. Healing of trabeculectomies in rabbits. Can J Ophthalmol 1979;14:121-5.
30. Pfeiffer RL, Lipper S, Merritt JC, et al. Myofibroblasts in the healing of filtering wounds in rabbit, dog, and cat. Glaucoma 1981;3:277-80.
31. Rich AM, McPherson SD. Trabeculectomy in the owl monkey. Ann Ophthalmol 1973;5:1082-8.
32. Desjardins DC, Parrish RK, Folberg R, et al. Wound healing after filtering surgery in owl monkeys. Arch Ophthalmol 1986;104:1835-9.